Amplia Therapeutics Ltd.ASX: ATX

Dose Escalation Approved in ACCENT Clinical Trial of AMP945

Apr 11, 2023 at 6:38 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment